Evidence map›Paper›PMID 30664664›Full record

ArticleLeukemia2019

Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells.

Pratikkumar H Vekaria, Amar Kumar, Dharmalingam Subramaniam, Neil Dunavin, Anusha Vallurupalli, Frank Schoenen, Siddhartha Ganguly, Shrikant Anant, Joseph P McGuirk, Roy A Jensen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Pratikkumar H VekariaDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kanas City, KS, USA.
Amar KumarDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kanas City, KS, USA.
Dharmalingam SubramaniamDepartment of Cancer Biology, The University of Kansas Cancer Center, Kanas City, KS, USA.
Neil DunavinDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kanas City, KS, USA.
Anusha VallurupalliDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kanas City, KS, USA.
Frank SchoenenHiguchi Biosciences Center, University of Kansas, Lawrence, KS, USA.
Siddhartha GangulyDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kanas City, KS, USA.
Shrikant AnantDepartment of Cancer Biology, The University of Kansas Cancer Center, Kanas City, KS, USA.ORCID http://orcid.org/0000-0003-4193-3053
Joseph P McGuirkDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kanas City, KS, USA.
Roy A JensenDepartment of Pathology & Laboratory Medicine, The University of Kansas Cancer Center, Kansas City, KS, USA.ORCID http://orcid.org/0000-0003-4430-2281
Rekha RaoDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kanas City, KS, USA. rraomanepalli@kumc.edu.
The University of Kansas Cancer Center · USUniversity of Kansas · US

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
Bitter Melon Component and Colon Cancer PreventionR01CA190291 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ANANT, SHRIKANT, UMAR, SHAHID · 2014 to 2018
$2.7M
NCI NIH HHS P30 CA168524NCI NIH HHS R01 CA190291
6 · The paper itself

Abstract

p97 is an ATPase that works in concert with histone deacetylase 6 (HDAC6), to facilitate the degradation of misfolded proteins by autophagosomes. p97 has also been implicated in DNA repair and maintaining genomic stability. In this study, we determined the effect of combined inhibition of p97 and HDAC6 activities in mantle cell lymphoma (MCL) cells. We report that treatment with p97 inhibitors induces dose-dependent apoptosis in MCL cells. The p97 inhibitor CB-5083 induces ER stress markers GRP78 and CHOP and results in the accumulation of polyubiquitylated proteins. Co-treatment with CB-5083 and the HDAC6 inhibitor ACY-1215 result in marked downregulation of CDK4, Cyclin D1, and BRCA1 levels without inhibiting autophagic flux. Consequently, treatment with CB-5083 accentuates DNA damage in response to treatment with ACY-1215 resulting in enhanced accumulation of H2AX-γ and synergistic apoptosis. Furthermore, ATM loss severely impairs phosphorylation of 53BP1 following co-treatment with CB-5083 and ACY-1215 in response to gamma irradiation. Finally, co-treatment CB-5083 and ACY-1215 results in reduced tumor volumes and improves survival in Z138C and Jeko-1 xenografts in NSG mice. These observations suggest that combined inhibition of p97 and HDAC6 abrogates resolution of proteotoxic stress and impairs DNA repair mechanisms in MCL cells.

Indexed as

Drug SynergismAdenosine TriphosphatasesAnimalsApoptosisAutophagyCell ProliferationDNA DamageDNA RepairDrug Therapy, CombinationEndoplasmic Reticulum Chaperone BiPGene Expression Regulation, NeoplasticHistone Deacetylase 6Histone Deacetylase InhibitorsHumansHydroxamic AcidsIndolesAdenosine TriphosphatasesCB-5083Endoplasmic Reticulum Chaperone BiPHDAC6 protein, humanHistone Deacetylase 6Histone Deacetylase InhibitorsHSPA5 protein, humanHspa5 protein, mouseHydroxamic AcidsIndolesNuclear Proteinsp97 ATPasePyrimidinesricolinostat

Identifiers

PMID30664664
PMCPMC6730676
OpenAlexW2909231646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.